Novel Effect of Antihelminthic Niclosamide on S100A4-Mediated Metastatic Progression in Colon Cancer
Ulrike Sack(Charité - Universitätsmedizin Berlin), Ulrike Stein(Max Delbrück Center)
Cited by 211
Related Papers
Epigenetic silencing of miR-520c leads to induced S100A4 expression and its mediated colorectal cancer progression
|Oncotarget|2017|55
The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis
|Oncogene|2021|14
The importance of developing therapies targeting the biological spectrum of metastatic disease
|Clinical & Experimental Metastasis|2019|13